logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
P

PULMONARY PHARMACOLOGY & THERAPEUTICS

IF2.8
论文数29
被引数4
期刊论文 29
发表时间
delete
Tectochrysin Alleviates Idiopathic Pulmonary Fibrosis via Inhibiting PI3K/AKT/mTOR Signaling Pathway by Targeting PI3K p85槲皮素通过靶向PI3K p85抑制PI3K/AKT/mTOR信号通路减轻特发性肺纤维化
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-10-28
delete0
PREAI
deleteMengying Li; Tingfang Xiao; Xuanyu Chen; Zhihe Liu; Haoyu Ji; Huiwen Chen; Xinru Xi; Yali Zhang; Xiaona Zhu
delete分享
delete收藏
Cellular Senescence and Vascular Ageing in Pulmonary Hypertension: Molecular Mechanisms, Therapeutic Strategies, and Translational Endpoints肺动脉高压中的细胞衰老与血管衰老：分子机制、治疗策略与转化终点
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-10-23
delete0
PREAI
deleteYide Chen; Xiaolan Wang; Meng Gao; Qinei Zheng; Qianyue Zhang; Ting Liu; Shuanglan Xu; Jiao Yang; Xiqian Xing
delete分享
delete收藏
Pharmacological Enhancement of O-GlcNAcylation Attenuates Lung Ischemia-Reperfusion Injury药物增强O-GlcNAc糖基化可减轻肺缺血再灌注损伤
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-10-17
delete0
PREAI
deleteYang Jin; Yu Fu; Nan Zhang; Xuemei Jiang; Jiameng Gao; Zhiyuan Zhang; Xiaotong Huang; Maojun Zhou; Chang Chen; Zongmei Wen
delete分享
delete收藏
First-in-Human Safety and Pharmacokinetic Evaluation of Seralutinib, an Investigational Inhaled Tyrosine-protein Kinase Inhibitor for Pulmonary Hypertension首次人体安全性及药代动力学评价：一种用于肺动脉高压的试验性吸入酪氨酸蛋白激酶抑制剂Seralutinib
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-10-13
delete0
PREAI
deleteJianke Li; Lawrence S. Zisman; Matt Cravets; Richard Aranda
delete分享
delete收藏
Belumosudil Improves Experimental Pulmonary Fibrosis via the ROCK2/Smad3/CTGF Pathway贝卢莫舒迪尔通过ROCK2/Smad3/CTGF通路改善实验性肺纤维化
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-10-01
delete0
PREAI
deleteDexin Kong; Guanghua Zhang; Zhonghong Jiang; Wanglin Jiang
delete分享
delete收藏
Steroid-sparing strategies in respiratory diseases: efficacy and safety of current therapeutic options呼吸系统疾病中的类固醇节约策略：当前治疗方案的疗效与安全性
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-09-23
delete0
PREAI
deleteMateusz Gadzała; Aleksandra Paź; Dagmara Mirowska-Guzel
delete分享
delete收藏
Targeting pulmonary and arterial chemoreceptors via inhaled therapeutics: A novel pathway to blunt hypoxia-induced pulmonary hypertension?通过吸入疗法靶向肺和动脉化学感受器：一种减轻低氧诱导性肺动脉高压的新途径？
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-09-23
delete0
PREAI
deleteDurlav Chowdhury; Surendra H. Bodakhe
delete分享
delete收藏
TNF-α–mediated molecular switching links COPD to lung cancer: Integrated in silico and in vivo study of oxidative stress–driven disease transitionTNF-α介导的分子开关连接COPD与肺癌：氧化应激驱动的疾病转变的整合计算机模拟与体内研究
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-09-06
delete0
PREAI
deleteRiya Manna; Jagannath Das; Debraj Roy; Sampurna Bhattacharya; Sudipto Saha; Runa Sur; I.B. Chatterjee; Rajat Banerjee
delete分享
delete收藏
The preclinical discovery and development of depemokimab for severe eosinophilic asthmadepemokimab治疗严重嗜酸性哮喘的预临床发现与开发
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-09-01
delete1
PREAI
deleteCazzola, Mario; Patella, Vincenzo; Pagliaro, Raffaella; Bianco, Andrea; Rogliani, Paola; Matera, Maria Gabriella
delete分享
delete收藏
Efficacy and safety of magnesium glycinate as add on therapy in hypomagnesemic asthma and chronic obstructive pulmonary disease patients: A randomised controlled study assessing inflammatory biomarkers甘氨酸镁作为补充疗法在低镁血症哮喘和慢性阻塞性肺疾病患者中的疗效与安全性：一项评估炎症生物标志物的随机对照研究
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-08-23
delete0
PREAI
deleteManeesh Kumar Maddirevula; Muhasaparur G. Rajanandh; Boman Wesley
delete分享
delete收藏
m6A reader IGF2BP2 mediates airway remodeling by stabilizing Dixdc1 in asthma pathogenesism6A阅读器IGF2BP2通过稳定Dixdc1介导哮喘发病机制中的气道重塑
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-08-01
delete0
PREAI
deleteLi, Xiao-Mang; Mo, Bi-Wen; Gao, Yan; Chen, Yun-Xiang; Xiao, Bo; Gu, Yue; Liang, Miao-Miao; Li, Hui-Min
delete分享
delete收藏
Real-life application of the optical beta-adrenergic sweat test for people with cystic fibrosis光学β-肾上腺素汗液测试在囊性纤维化患者中的实际应用
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-17
delete0
PREAI
deleteKarina Kleinfelder; Anca Manuela Hristodor; Giorgio Centin; Antonella Casiraghi; Paola Minghetti; Emily Pintani; Marina Bertini; Claudio Sorio; Paola Melotti
delete分享
delete收藏
Effects of anumigilimab, an anti–G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers抗G-CSF受体单克隆抗体anumigilimab在分段LPS挑战后的效果：一项在健康志愿者中进行的1b期临床试验
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-06
delete0
deleteOAAI
deleteJens M. Hohlfeld; Meike Müller; Philipp Badorrek; Laurent B. Nicolas; Oliver Vit; William G. Darby; Judith Field; Michael Larbig
delete分享
delete收藏
Methodological considerations on the effectiveness of biologics in asthma-COPD overlap哮喘-COPD重叠综合征中生物制剂疗效的方法学考量
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-01
delete0
PREAI
deleteLiu, Tingfang; Jian, Ye
delete分享
delete收藏
Brain-derived neurotrophic factor (BDNF) signaling in respiratory disease: Mechanisms, neuroimmune crosstalk, and therapeutic implications脑源性神经营养因子（BDNF）信号在呼吸系统疾病中的作用：机制、神经免疫串扰及其治疗意义
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-01
delete0
PREAI
deleteEntesar Yaseen Abdo Qaid; Idris Long
delete分享
delete收藏
TROP2 as a Promising Therapeutic Target in Lung Cancer: Current Clinical Trial Landscape and Future DirectionsTROP2作为肺癌中有前景的治疗靶点：当前临床试验格局及未来方向
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-06-09
delete0
PREAI
deleteMaosen Liu; Ruihang Luo; Yichen Liu; Yuxin Fan; Jingtao Zhang; Mingshan Liu
delete分享
delete收藏
PD05, a novel neutrophil elastase inhibitor, mitigates LPS-induced acute lung injury in a preclinical modelPD05，一种新型中性粒细胞弹性蛋白酶抑制剂，减轻了LPS诱导的预临床模型中的急性肺损伤
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-06-01
delete0
PREAI
deleteSingh, Sabita; Jaiswal, Ashish; Dutta, Joytri; Ray, Archita; Sengupta, Sayantan; Dey, Sudip; Bandyopadhyay, Arun; Jaisankar, Parasuraman; Mabalirajan, Ulaganathan
delete分享
delete收藏
Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment通过联合双氢青蒿素和木脂素处理靶向TOP2A协同诱导肺癌细胞凋亡
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-05-05
delete0
PREAI
deleteHaidi Sun; Li Han; Hongwei Wu; Hongsheng Xue; Ming-Fei Lang; Jingyu Tan
delete分享
delete收藏
Evodiamine protects against lung ischemia–reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures艾瑟达明通过减轻SYK相关的TLR4/NLRP3炎症小体激活和铁死亡相关损伤标志物，对肺缺血再灌注损伤起到保护作用。
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-04-06
delete0
PREAI
deleteWei Peng; Baiping Ge; Rui Zhang; Yunen Liu; Changci Tong; Chenguang Dong
delete分享
delete收藏
Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients评估调节剂疗法对成人囊性纤维化患者用药复杂性的影响
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-03-10
delete0
PREAI
deleteEsen Deniz Akman Ar; Nadir Yalçın; Uğur Balaban; Oğuz Karcıoğlu; Ebru Damadoğlu; Ali Fuat Kalyoncu; Kutay Demirkan
delete分享
delete收藏